HPV vaccines long-term safety unknown, say reviewersNovember 13th, 2008 - 4:52 pm ICT by ANI
Washington, November 13 (ANI): A scientific review has raised several concerns regarding mandating HPV vaccination as a condition for school attendance.
The HPV vaccine, sold as Gardasil in the U.S., is intended to prevent four strains of the human papillomavirus, the most common sexually transmitted infection in the world. It also prevents against cervical cancer.
Gail Javitt, Deena Berkowitz, and Lawrence O. Gostin of the Berman Institute of Bioethics at Johns Hopkins University assert that Gardasil is relatively new and long-term safety and effectiveness in the general population is unknown.
They say that outcome of those voluntarily vaccinated should be followed for several years before mandates are imposed.
According to them, the HPV vaccine does not represent a public health necessity of the type that has justified previous vaccine mandates, and thus raises Constitutional concerns.
The reviewers argue that state mandates may lead to a public backlash that will undermine both HPV vaccination efforts, and existing vaccination programs.
Shedding light on the economic consequences of mandating HPV, they note that it may have a negative impact on financial support for other vaccines and public health programs.
The reviewers insist that such consequences should be evaluated before the vaccine is mandated.
HPV will not be the last disease that state legislatures will attempt to prevent through mandatory vaccination. This is a good time to reevaluate the criteria that should be used to mandate vaccination of children as a condition of school attendance, the authors conclude.
The article has been published in the Journal of Law, Medicine & Ethics. (ANI)
- Vaccination can prevent cervical cancer deaths: Experts - Aug 07, 2012
- Twin viruses linked to prostate cancer - Aug 03, 2012
- Shot for preventing genital warts works in men - Feb 06, 2011
- HPV vaccine also works for boys: Study - Feb 05, 2011
- Oral sex putting men at risk for throat cancer - Oct 21, 2010
- Only one-third of young US girls receive HPV vaccine for cervical cancer - Jun 02, 2010
- Brinda questions cervical cancer vaccines programme - Apr 08, 2010
- How virus triggers cervical and mouth cancer - Dec 15, 2010
- India capable of producing lower-cost HPV vaccine - Jul 10, 2010
- Cancer vaccine kicks up controversy in India - Dec 30, 2008
- Oral sex bigger cause of throat cancer than tobacco - Feb 21, 2011
- Mums play key role in convincing daughters to receive HPV vaccine - Jan 04, 2011
- Panel report on HPV vaccine trials slammed - May 09, 2011
- Oral sex, HPV puts non-smoking US men at highest risk for oral cancer - Apr 19, 2011
- Girls aware of HPV vaccine's benefits: US study - Oct 16, 2009
Tags: cervical cancer, constitutional concerns, economic consequences, gardasil, hpv vaccination, hpv vaccine, hpv vaccines, johns hopkins university, journal of law medicine, lawrence o gostin, mandatory vaccination, public backlash, public health programs, school attendance, state legislatures, state mandates, term safety, vaccination efforts, vaccination programs, vaccine mandates